Science and Research

COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension

BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary arterial hypertension (PAH). The current European guidelines propose a 3-strata model to categorise risk as low, intermediate, or high, based on the expected 1-year mortality. However, with this model, most patients are categorised as intermediate risk. We investigated a modified approach based on 4 risk categories with intermediate risk subdivided into intermediate-low and intermediate-high risk. METHODS: We analysed data from COMPERA, a European pulmonary hypertension registry, and calculated risk at diagnosis and first follow-up based on functional class (FC), 6 min walking distance (6 MWD) and serum levels of brain natriuretic peptide (BNP) or N-terminal fragment of pro-BNP (NT-proBNP), using refined cut-off values. Survival was assessed with Kaplan-Meier analyses, log-rank testing, and Cox proportional hazards models. RESULTS: Data from 1,655 patients with PAH were analysed. Using the 3-strata model, most patients were classified as intermediate risk (76.0% at baseline and 63.9% at first follow-up). The refined 4-strata risk model yielded a more nuanced separation and predicted long-term survival, especially at follow-up assessment. Changes in risk from baseline to follow-up were observed in 31.1% of the patients with the 3-strata model and in 49.2% with the 4-strata model. These changes, including those between the intermediate-low and intermediate-high strata, were associated with changes in long-term mortality risk. CONCLUSIONS: Modified risk stratification using a 4-strata model based on refined cut-off levels for FC, 6MWD and BNP/NT-proBNP was more sensitive to prognostically relevant changes in risk than the original 3-strata model.

  • Hoeper, M. M.
  • Pausch, C.
  • Olsson, K. M.
  • Huscher, D.
  • Pittrow, D.
  • Grünig, E.
  • Staehler, G.
  • Vizza, C. D.
  • Gall, H.
  • Distler, O.
  • Opitz, C.
  • Gibbs, J. S. R.
  • Delcroix, M.
  • Ghofrani, H. A.
  • Park, D. H.
  • Ewert, R.
  • Kaemmerer, H.
  • Kabitz, H. J.
  • Skowasch, D.
  • Behr, J.
  • Milger, K.
  • Halank, M.
  • Wilkens, H.
  • Seyfarth, H. J.
  • Held, M.
  • Dumitrescu, D.
  • Tsangaris, I.
  • Vonk-Noordegraaf, A.
  • Ulrich, S.
  • Klose, H.
  • Claussen, M.
  • Lange, T. J.
  • Rosenkranz, S.
Publication details
DOI: 10.1183/13993003.02311-2021
Journal: Eur Respir J
Work Type: Original
Location: ARCN, BREATH, CPC-M, TLRC
Disease Area: PH
Partner / Member: Ghd, JLU, KUM, MHH, Thorax
Access-Number: 34737226

DZL Engagements

chevron-down